ALKS

Alkermes plc News Headlines

$46.31
*  
1.62
3.62%
Get ALKS Alerts
*Delayed - data as of Jul. 30, 2014 15:26 ET  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALKS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues - Analyst Blog
7/30/2014 12:04:00 PM - Zacks.com

Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
7/21/2014 4:40:00 PM - Zacks.com

Alkermes Begins Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis
7/17/2014 7:37:00 AM - RTT News

Alkermes plc (ALKS) Jumps: Stock Rises 5.7% - Tale of the Tape
6/23/2014 9:21:00 AM - Zacks.com

Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog
6/19/2014 11:40:00 AM - Zacks.com

Sector Update: Healthcare
6/18/2014 8:55:02 AM - MT Newswires

Sector Update: Healthcare Shares Flat Pre-Market; Pfizer Teams with Cellectis on Immunotherapy
6/18/2014 8:51:02 AM - MT Newswires

Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha

Alkermes Progresses with its Late Stage Candidate - Analyst Blog
6/11/2014 5:00:00 PM - Zacks.com

Alkermes To Present At Goldman Sachs Conference; Webcast At 5:40 PM ET
6/10/2014 3:01:00 PM - RTT News

Alkermes' Pipeline Holds Promise - Analyst Blog
6/6/2014 4:30:00 PM - Zacks.com

Alkermes To Present At Jefferies Healthcare Conference; Webcast At 11:00 AM ET
6/2/2014 10:00:00 AM - RTT News

Wider-than-expected Loss at Alkermes, Revenues Slip - Analyst Blog
5/1/2014 11:50:01 AM - Zacks.com

Sector Update: Healthcare
4/30/2014 8:54:36 AM - MT Newswires

Sector Update: Healthcare Shares Mixed Pre-Market; WellPoint up 2% on Q1 Results
4/30/2014 8:51:51 AM - MT Newswires

Xenoport's Path Is Long, But The Potential Is There
4/17/2014 8:31:00 PM - Seeking Alpha

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
4/16/2014 10:07:01 AM - Zacks.com

Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
4/11/2014 9:00:01 AM - Zacks.com

Halozyme Study Under Clinical Hold - Analyst Blog
4/10/2014 5:40:01 PM - Zacks.com

ImmunoGen Up on Positive Pipeline Data - Analyst Blog
4/10/2014 5:00:01 PM - Zacks.com

Gilead Announces Encouraging Sovaldi Data - Analyst Blog
4/10/2014 4:37:01 PM - Zacks.com

3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog
4/10/2014 9:22:01 AM - Zacks.com

Cramer's Lightning Round - Kimberly-Clark Is Perfect For Me (4/9/14)
4/10/2014 5:42:00 AM - Seeking Alpha

Oncolytics Reports Additional Data on Reolysin - Analyst Blog
4/9/2014 6:30:01 PM - Zacks.com

Ambit's Oncology Drug in Phase III - Analyst Blog
4/9/2014 4:55:01 PM - Zacks.com